Iveda Solutions, Inc. Stock Compensation Disclosure
NOTE 10 STOCK OPTION PLAN AND WARRANTS
Stock Options
On October 15, 2009, we adopted the 2009 Stock Option Plan (the 2009 Option Plan), with an aggregate number of 1,500,000 shares of common stock issuable under the plan. The purpose of the 2009 Option Plan was to assume options that were already issued in the 2006 and 2008 Option plans under Iveda Corporation after the merger with Charmed Homes. As of December 31, 2015, options to purchase 745,554 shares of our common stock were outstanding under the 2009 Option Plan.
On January 18, 2010, we adopted the 2010 Stock Option Plan (the 2010 Option Plan), which allows the Board to grant options to purchase up to 1,000,000 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 3,000,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 13,000,000 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333-164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). As of December 31, 2015, options to purchase 5,292,200 shares of our common stock were outstanding under the 2010 Option Plan.
Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the Code), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.
We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options vesting periods. At December 31, 2015, we had unrecognized stock-based compensation of $22,157 with a weighted-average term of approximately three years.
Stock option transactions during 2015 and 2014 were as follows:
| 2015 | 2014 | |||||||||||||||
| Shares | Weighted- Average Exercise Price |
Shares | Weighted- Average Exercise Price |
|||||||||||||
| Outstanding at Beginning of Year | 5,953,227 | $ | 1.03 | 5,693,322 | $ | 1.07 | ||||||||||
| Granted | 1,048,000 | 0.72 | 1,322,000 | 1.22 | ||||||||||||
| Exercised | (23,140 | ) | 0.10 | (56,345 | ) | 0.10 | ||||||||||
| Forfeited or Canceled | (940,333 | ) | 1.17 | (1,005,750 | ) | 1.55 | ||||||||||
| Outstanding at End of Year | 6,037,754 | 0.96 | 5,953,227 | 1.03 | ||||||||||||
| Options Exercisable at Year-End | 5,969,879 | 0.97 | 5,577,185 | 1.10 | ||||||||||||
| Weighted-Average Fair Value of Options Granted During the Year | $ | 0.15 | $ | 0.25 | ||||||||||||
Information with respect to stock options outstanding and exercisable at December 31, 2015 is as follows:
| Options Outstanding | Options Exercisable | |||||||||||||||||||
| Range of Exercise Prices |
Number Outstanding at December 31, 2015 | Weighted-Average Remaining Contractual Life | Weighted-Average Exercise Price | Number Exercisable at December 31, 2015 | Weighted-Average Exercise Price | |||||||||||||||
| $0.10 - $1.75 | 6,037,754 | 7 | $ | 0.96 | 5,969,879 | $ | 0.97 | |||||||||||||
The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.
| 2015 | 2014 | |||||||
| Expected Life | 6.7 yrs | 6.25 yrs | ||||||
| Dividend Yield | 0 | % | 0 | % | ||||
| Expected Volatility | 18 | % | 18 | % | ||||
| Risk-Free Interest Rate | 2.09 | % | 2.26 | % | ||||
Expected volatility for 2015 and 2014 was estimated by using the Dow Jones U.S. Industry Indices sector classification methodology for industries similar to that in which we operate. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the grant date. The expected life of the options is based on the actual expiration date of the grant.
Warrants
We have also periodically issued warrants to purchase shares of common stock as equity compensation to officers, directors, employees, and consultants.
As of December 31, 2015, warrants to purchase 7,417,303 shares of common stock were outstanding, all of which were issued either as equity compensation or in connection with financing transactions. Warrants may be exercised between a range of two to ten years following the date of the grant, with vesting schedules determined by us upon issue. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. The fair value of warrants is determined using the Black-Scholes option-pricing model. The estimated fair value of warrants is recognized as expense on the straight-line basis over the warrants vesting periods.
Stock warrant transaction for 2015 and 2014 were as follows:
| 2015 | 2014 | |||||||||||||||
| Shares | Weighted-Average Exercise Price | Shares | Weighted-Average Exercise Price | |||||||||||||
| Outstanding at Beginning of Year | 3,749,550 | $ | 1.00 | 3,883,641 | $ | 1.00 | ||||||||||
| Granted | 4,369,162 | 1.05 | 674,909 | 1.36 | ||||||||||||
| Exercised | - | - | (530,000 | ) | 0.96 | |||||||||||
| Forfeited or Canceled | (701,409 | ) | 0.80 | (279,000 | ) | 1.08 | ||||||||||
| Outstanding at End of Year | 7,417,303 | 0.97 | 3,749,550 | 0.97 | ||||||||||||
| Warrants Exercisable at Year-End | 7,417,303 | 0.97 | 3,749,550 | 0.97 | ||||||||||||
| Weighted-Average Fair Value of Warrants Granted During the Year | $ | 0.20 | $ | 0.15 | ||||||||||||
Information with respect to warrants outstanding and exercisable at December 31, 2015 is as follows:
| Warrants Outstanding | Warrants Exercisable | |||||||||||||||||||
| Range of Exercise Prices |
Number Outstanding at December 31, 2015 | Weighted-Average Remaining Contractual Life | Weighted-Average Exercise Price | Number Exercisable at December 31, 2015 | Weighted-Average Exercise Price | |||||||||||||||
| $0.10 - $1.65 | 7,417,303 | 2.4 Years | $ | 1.00 | 7,417,303 | $ | 1.00 | |||||||||||||
The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for warrants granted.
| 2015 | 2014 | |||||||
| Expected Life | 2.4 | 2.8 | ||||||
| Dividend Yield | 0 | % | 0 | % | ||||
| Expected Volatility | 18 | % | 19 | % | ||||
| Risk-Free Interest Rate | 1.96 | % | 1.40 | % | ||||
Expected volatility was estimated by using the Dow Jones U.S. Industry Indices sector classification methodology for industries similar to ours. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the grant date. The expected life of warrants is based on the average of three public companies offering services similar to ours.
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.